Advice on anti-diabetes drug


  • Nation Premium
  • Monday, 27 Sep 2010

PETALING JAYA: Doctors should restrict their prescription of anti-diabetes medicine rosiglitazone and not start it on new patients following fears that it may increase cardiovascular problem.

The Drug Control Authority said diabetic patients who were put on the drug should also seek their doctors’ advice on whether they should continue with it.

Article type: metered
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights
   

Next In Nation

Guan Eng’s lawyer challenges admissibility of late developer’s statements Premium
Police, government's appeal against Indira Gandhi's nonfeasance suit to be heard on April 18 next year Premium
Pilot injured in RMAF Hawk crash still in hospital, says Armed Forces chief Premium
Covid-19: SOP compliance needs to be stricter amid emergence of Omicron, says Sabah Health director Premium
Covid-19: Sarawak's new cases stay below 100 for second consecutive day Premium
Covid-19: Malaysia to delay transition to endemic phase due to Omicron fears, says Hisham Premium
Johor Ruler expresses disappointment over Sg Danga pollution Premium
Two arrested, drugs worth over RM200,000 seized in JB Premium
PAS MP raises short skirt issue in Parliament Premium
Erroneous to conclude donations in Zahid’s charity foundation were proceeds from illegal activities, court told Premium

Others Also Read


Vouchers